Douglas H. Thamm
Technik-/Wissenschafts-/F&E-Leiter bei Csu Flint Animal Cancer Center
Profil
Douglas H.
Thamm is currently the Director of Clinical Research at CSU Flint Animal Cancer Center, Head of Clinical Development at VetDC, Inc., and a Member of the Cell & Molecular Biology Graduate Program at Colorado State University.
He received his undergraduate and doctorate degrees from the University of Pennsylvania.
Aktive Positionen von Douglas H. Thamm
Unternehmen | Position | Beginn |
---|---|---|
VetDC, Inc.
VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Corporate Officer/Principal | - |
Csu Flint Animal Cancer Center | Technik-/Wissenschafts-/F&E-Leiter | - |
Colorado State University | Corporate Officer/Principal | - |
Ausbildung von Douglas H. Thamm
University of Pennsylvania | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
VetDC, Inc.
VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Process Industries |
Csu Flint Animal Cancer Center |